INDIA – Lupin Diagnostics Limited, a wholly owned subsidiary of Lupin Limited, has opened its new ultramodern regional reference laboratory in Chennai in the southern Indian state of Tamil Nadu.

The company began its journey by establishing a state-of-the-art National Reference Laboratory located in Navi Mumbai with world-class equipment, experienced doctors assisted by trained technologists and stringent quality control protocols.

In a press release, Ravindra Kumar, Chief Executive Officer of Lupin Diagnostics said: “The launch of our state-of-the-art Regional Reference Laboratory in Chennai signifies a significant step toward accessible and reliable healthcare.”

The launch of the new regional reference laboratory in Chennai presents a unique opportunity for Lupin Diagnostics to expand its presence in South India.

This expansion marks a pivotal moment in the company’s commitment to providing accessible, affordable, and quality diagnostic healthcare services in the region.

With cutting-edge technology and a team of dedicated experts, we aim to redefine healthcare experiences, fostering a society where accurate diagnosis is a cornerstone of well-being,” divulged Ravindra Kumar.

Recognizing the rising demand for quality diagnostic services, the regional reference laboratory in Chennai is equipped with cutting-edge diagnostic technologies and a team of highly qualified clinical experts.

The inauguration of the Chennai-based lab comes shortly after Lupin Diagnostics launched its first-ever Regional Reference Laboratory in South India located in Hyderabad, Telangana.

This strategic move represents a key milestone towards consolidating the company’s position as India’s leading diagnostic network and a trusted leader in the healthcare industry.

Speaking on the launch, Ravindra Kumar stated: “Our vision extends beyond lab tests; it encompasses a commitment to empowering doctors and patients through precise, evidence-based diagnostics.”

Notably, Lupin Diagnostics offers a wide range of high-quality diagnostic services, including molecular diagnostics, cytogenetics, flow cytometry, cytology, microbiology, serology, and haematology, in addition to routine and specialized tests,

Lupin Diagnostics prioritizes accuracy and quality by following stringent quality control protocols. What’s more, temperature-controlled sample movement ensures the consistent integrity and quality of each sample.

With a robust home collection service team and network, the company prioritizes patient convenience, allowing real-time tracking of assigned phlebotomists.

The company also enhances its value-added services with dynamic smart reports, health monitoring tips, and historical trend graphs for patients.

Consequently, the new regional reference laboratory in Chennai will enhance Lupin Diagnostics’ capacity to deliver highly accurate test results, empowering patients to make informed decisions about their health.

This expansion reflects our relentless dedication towards patient-centricity and purpose of being a catalyst for healthier lives,” underscored Ravindra Kumar.

Moreover, the new regional reference laboratory complements the company’s extensive network, which now comprises 36 laboratories, over 600 collection exclusive collection centers (LupiMitra), and over 2200 pick-up points across India.

For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.